This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. (CRL) rallied 1.67% to $152.43 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&amp;P 500 Index falling 0.67% to 7,353.61 and Dow Jones Industrial Average falling 0.65% to 49,363.88.
The stock's rise snapped a four-day losing streak.
Charles River Laboratories International Inc. closed 33.40% below its 52-week high of $228.88, which the company reached on January 13th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Labcorp Holdings Inc. (LH) fell 0.74% to $253.69, Alnylam Pharmaceuticals Inc. (ALNY) rose 2.81% to $294.30, and Bio-Techne Corp. (TECH) rose 2.34% to $45.47.
Trading volume (1.1 M) eclipsed its 50-day average volume of 878,841.
Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-19-26 1717ET

ARKG

Charles River Laboratories International Inc. (CRL) shares rose 1.67% to $152.43, breaking a four-day losing streak, despite a poor overall market day. The S&P 500 fell 0.67% and the Dow Jones dropped 0.65%. CRL's stock remains 33.40% below its 52-week high of $228.88. Competitors had mixed results, with Labcorp down 0.74% and Alnylam Pharmaceuticals and Bio-Techne rising 2.81% and 2.34%, respectively.

MarketWatch Automated

Charles River Laboratorie

VanEck Biotech ETF

Ark Genomic Revolution ETF

Direxion S&P Biotech Bull 3X

Invesco Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

SPDR S&P Biotech

S&P 500

Dow Jones Industrial Average

Labcorp

Alnylam Pharma

Bio-Techne

Factset Research

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day